IL10 and cranial nerve palsy: In the CARTITUDE-4 trial, patients who developed cranial nerve palsies were likewise found to have elevated levels of interleukins, specifically IL-10 and IL-2Ra, as well as greater CAR T-cell expansion compared to patients without neurologic involvement (58).